CA Patent

CA2079982A1 — Substituted pyrazino (2,3-d)-pyrimidinones as angiotensin ii antagonists

Assigned to EIDP Inc · Expires 1993-04-08 · 33y expired

What this patent protects

TITLE OF THE INVENTION SUBSTITUTED PYRAZINO[2,3-D]PYRIMIDINONES AS ANGIOTENSIN II ANTAGONISTS ABSTRACT OF THE INVENTION Novel substituted pyrazino[2,3-d]pyrimidi-nones of formula (I), are angiotensin II antagonists, useful in the treatment (I) of hypertension a…

USPTO Abstract

TITLE OF THE INVENTION SUBSTITUTED PYRAZINO[2,3-D]PYRIMIDINONES AS ANGIOTENSIN II ANTAGONISTS ABSTRACT OF THE INVENTION Novel substituted pyrazino[2,3-d]pyrimidi-nones of formula (I), are angiotensin II antagonists, useful in the treatment (I) of hypertension and related disorders and in certain CNS disorders.

Drugs covered by this patent

Patent Metadata

Patent number
CA2079982A1
Jurisdiction
CA
Classification
—
Expires
1993-04-08
Drug substance claim
No
Drug product claim
No
Assignee
EIDP Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.